Developer docs
API playgroundTry for free, no card

Search company profiles

InterWest Partners

Full company profile

uuid003vmhk

Namestring
InterWest Partners
Legal namestring
InterWest Venture Management Co.
Websiteurl
interwest.com
Company typeenum
Private
Founded yearint
1980
Descriptiontext

InterWest Partners is a private venture capital firm founded in 1979-1980 (per firmographic and corporate-history sources) and headquartered in the San Francisco Bay Area (mailing address at 548 Market St., PMB 44661, San Francisco, CA 94104). The firm specializes in early-stage investments in information technology and healthcare/life sciences startups, historically deploying an average of approximately $7-15 million per portfolio company over the span of its involvement. InterWest does not build or sell technology products; its offering is equity capital combined with strategic partnership to founding teams, with monetization occurring through portfolio company exits via IPOs and strategic acquisitions, supplemented by fund management fees from limited partners.

Over four decades of operation, InterWest has backed a broad portfolio of more than 25 named companies spanning semiconductors (Xilinx, Cyrix, Copper Mountain Networks), enterprise software (C3.ai, Marketo, Pipedrive, Braze, Tapjoy, Vungle), healthcare devices and biotech (Glaukos, IntraLase, LenSx Lasers, Tesaro, PMV Pharma, Myogen, Amplimmune, AkaRx, Aspreva, Aerie, Labrys, TheraSense, Corixa), and consumer/digital platforms (Canva, Doximity, TheRealReal, Lightera Networks, Ciena, Stratacom). Realized exits include Xilinx's acquisition by AMD for approximately $35 billion and Marketo's acquisition by Adobe for approximately $4.75 billion, alongside IPO outcomes for C3.ai, Braze, Doximity, TheRealReal, and Glaukos.

The firm is currently in a harvest posture: its website explicitly states that it is "not currently seeking new investments." The team has contracted to five identified members - Managing Partner Gil Kliman, General Partners Keval Desai and Khaled Nasr (also COO), CFO Karen Wilson, and Controller Katie Passalacqua - with legacy founders Wally Hawley, Gene Barth, and Scott Hedrick and managing directors Bruce Cleveland and Arnie Oronsky referenced as historical leaders. Canva appears to be the sole currently listed portfolio company, with Pipedrive and PMV Pharma referenced as ongoing holdings in supplementary data. Operating geographies are limited to the United States, and the firm uses minimal formal marketing channels, relying on four decades of reputational capital and professional networks for deal flow.

Short descriptiontext

InterWest Partners is a private, four-decade-old venture capital firm specializing in early-stage information technology and healthcare investments, historically deploying $7-15 million per portfolio company. The firm is currently not seeking new investments and is harvesting residual portfolio value, principally from Canva.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMenlo Park, United States
HQ citystring
Menlo Park
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital investing, early-stage IT investing, healthcare venture capital, startup equity funding, IT healthcare startup funding
Industry1 code
1Telecom, Networking & Infrastructure Growth Equity
CodeFSANACAJPrimaryYes
NAICS code1 code
  • Investment Banking and Securities Intermediation523150
SIC code1 code
  • Security Brokers, Dealers & Flotation Companies6211
Product category
Venture Capital
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Investment Returns
TypeLicensing Royalties
Description

Venture capital returns generated from equity investments in early-stage portfolio companies through exits via IPOs and acquisitions.

interwest.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

InterWest Partners is a venture capital firm that invests an average of $7-15 million in early-stage information technology and healthcare startups. The firm partners with entrepreneurs to provide growth capital and strategic guidance, generating returns through equity stakes in portfolio companies that exit via IPOs or acquisitions. InterWest is not currently seeking new investments and focuses on managing its existing portfolio across IT and healthcare sectors.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Successful exits including Xilinx (acquired by AMD for $35B), Marketo (acquired by Adobe), Ciena, and numerous other portfolio companies
Product overview1 text field

InterWest Partners is a venture capital firm that provides investment capital and strategic partnership to early-stage IT and healthcare startups. As a VC firm, InterWest does not offer software products or technology services—its offering is equity investment and operational partnership with entrepreneurs building companies in information technology and healthcare sectors. The firm maintains a portfolio of successful companies across these sectors, but the portfolio companies are separate entities that InterWest has invested in, not products or services offered by InterWest Partners itself.

Product and service2 records
1Early-Stage Venture Capital Investment
CategoryVenture Capital Investment
2Strategic Partnership and Operational Guidance
CategoryInvestment Advisory
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Early-stage venture firm investing in IT and healthcare from a Silicon Valley base, with a comparable multi-decade history and similar sector emphasis to InterWest.

TypeBroad incumbent
Description

Largest and most-established venture capital franchise with deep IT exposure; comparable to InterWest as a benchmark for category-defining IT investments though vastly larger in scale and active deployment.

TypeDirect peer
Description

Early-stage venture capital firm based in Silicon Valley focused on enterprise IT; comparable to InterWest in geography and stage, though narrower in vertical emphasis.

TypeDirect peer
Description

Diversified venture capital firm with IT and healthcare franchises and a multi-decade operating history; comparable to InterWest in sector breadth and long-tenured stage focus.

TypeDirect peer
Description

Long-standing early-stage venture firm with a parallel IT and healthcare focus and a similarly long track record of category-defining exits. Most directly comparable to InterWest by thesis, stage, and Silicon Valley geography.

TypeDirect peer
Description

Heritage early-stage venture firm with broad IT and healthcare exposure and a multi-decade operating history; comparable to InterWest as a long-tenured generalist stage-agnostic VC.

TypeDirect peer
Description

Large-scale venture capital firm with deep IT and healthcare franchises; comparable to InterWest in sector breadth and early-stage orientation, though operating at far greater scale.

TypeDirect peer
Description

Premier early-stage venture firm based in Silicon Valley with strong IT focus; comparable in stage, geography, and long tenure.

TypeBroad incumbent
Description

Major venture capital firm with a broad IT franchise and growing healthcare practice; comparable in stage and sector focus, but at far greater scale and recency of activity than InterWest.

TypeDirect peer
Description

Long-running early-stage venture capital firm with a similarly broad IT focus across enterprise and consumer software; comparable to InterWest in stage focus and tenure.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment453 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

InterWest Partners

Venture Capitalinterwest.com

InterWest Partners is a private, four-decade-old venture capital firm specializing in early-stage information technology and healthcare investments, historically deploying $7-15 million per portfolio company. The firm is currently not seeking new investments and is harvesting residual portfolio value, principally from Canva.

What InterWest Partners does

InterWest Partners is a private venture capital firm founded in 1979-1980 (per firmographic and corporate-history sources) and headquartered in the San Francisco Bay Area (mailing address at 548 Market St., PMB 44661, San Francisco, CA 94104). The firm specializes in early-stage investments in information technology and healthcare/life sciences startups, historically deploying an average of approximately $7-15 million per portfolio company over the span of its involvement. InterWest does not build or sell technology products; its offering is equity capital combined with strategic partnership to founding teams, with monetization occurring through portfolio company exits via IPOs and strategic acquisitions, supplemented by fund management fees from limited partners.

Over four decades of operation, InterWest has backed a broad portfolio of more than 25 named companies spanning semiconductors (Xilinx, Cyrix, Copper Mountain Networks), enterprise software (C3.ai, Marketo, Pipedrive, Braze, Tapjoy, Vungle), healthcare devices and biotech (Glaukos, IntraLase, LenSx Lasers, Tesaro, PMV Pharma, Myogen, Amplimmune, AkaRx, Aspreva, Aerie, Labrys, TheraSense, Corixa), and consumer/digital platforms (Canva, Doximity, TheRealReal, Lightera Networks, Ciena, Stratacom). Realized exits include Xilinx's acquisition by AMD for approximately $35 billion and Marketo's acquisition by Adobe for approximately $4.75 billion, alongside IPO outcomes for C3.ai, Braze, Doximity, TheRealReal, and Glaukos.

The firm is currently in a harvest posture: its website explicitly states that it is "not currently seeking new investments." The team has contracted to five identified members - Managing Partner Gil Kliman, General Partners Keval Desai and Khaled Nasr (also COO), CFO Karen Wilson, and Controller Katie Passalacqua - with legacy founders Wally Hawley, Gene Barth, and Scott Hedrick and managing directors Bruce Cleveland and Arnie Oronsky referenced as historical leaders. Canva appears to be the sole currently listed portfolio company, with Pipedrive and PMV Pharma referenced as ongoing holdings in supplementary data. Operating geographies are limited to the United States, and the firm uses minimal formal marketing channels, relying on four decades of reputational capital and professional networks for deal flow.

InterWest Partners firmographics

Firmographics
Name
InterWest Partners
Legal name
InterWest Venture Management Co.
Website
https://interwest.com
Company type
Private
Founded year
1980
Operating status
Operating
Headcount range
11–50 employees
Short description
InterWest Partners is a private, four-decade-old venture capital firm specializing in early-stage information technology and healthcare investments, historically deploying $7-15 million per portfolio company. The firm is currently not seeking new investments and is harvesting residual portfolio value, principally from Canva.
Ownership category
akta.pro rank

InterWest Partners industry classification

Industry
Product category
Venture Capital
NAICS
Investment Banking and Securities Intermediation (523150)
SIC
Security Brokers, Dealers & Flotation Companies (6211)
akta.pro primary industry
Telecom, Networking & Infrastructure Growth Equity (FSANACAJ)

Keywords

  • Venture capital investing
  • Early-stage IT investing
  • Healthcare venture capital
  • Startup equity funding
  • IT healthcare startup funding

Where InterWest Partners is headquartered

Location

Headquarters

HQ city
Menlo Park
HQ country
United States
HQ region
North America

Offices1 record

Markets served

InterWest Partners business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Others

Revenue model

  1. Investment Returns: Venture capital returns generated from equity investments in early-stage portfolio companies through exits via IPOs and acquisitions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

InterWest Partners product offering

Product offering

Core offering

InterWest Partners is a venture capital firm that invests an average of $7-15 million in early-stage information technology and healthcare startups. The firm partners with entrepreneurs to provide growth capital and strategic guidance, generating returns through equity stakes in portfolio companies that exit via IPOs or acquisitions. InterWest is not currently seeking new investments and focuses on managing its existing portfolio across IT and healthcare sectors.

Product overview

InterWest Partners is a venture capital firm that provides investment capital and strategic partnership to early-stage IT and healthcare startups. As a VC firm, InterWest does not offer software products or technology services—its offering is equity investment and operational partnership with entrepreneurs building companies in information technology and healthcare sectors. The firm maintains a portfolio of successful companies across these sectors, but the portfolio companies are separate entities that InterWest has invested in, not products or services offered by InterWest Partners itself.

Differentiator

Problem solved

Functional benefit

Products and services

  • Early-Stage Venture Capital Investment
  • Strategic Partnership and Operational Guidance

Quantifiable outcome

  • Successful exits including Xilinx (acquired by AMD for $35B), Marketo (acquired by Adobe), Ciena, and numerous other portfolio companies

Companies that use InterWest Partners

Customer profile

Segments2 records

Ideal customer profiles2 records

InterWest Partners technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

InterWest Partners partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves5 records

Expansion highlights3 records

InterWest Partners competitors and assessment

Company assessment

Direct peers

  • Venrock: Early-stage venture firm investing in IT and healthcare from a Silicon Valley base, with a comparable multi-decade history and similar sector emphasis to InterWest.
  • Mayfield Fund: Early-stage venture capital firm based in Silicon Valley focused on enterprise IT; comparable to InterWest in geography and stage, though narrower in vertical emphasis.
  • Norwest Venture Partners: Diversified venture capital firm with IT and healthcare franchises and a multi-decade operating history; comparable to InterWest in sector breadth and long-tenured stage focus.
  • Kleiner Perkins: Long-standing early-stage venture firm with a parallel IT and healthcare focus and a similarly long track record of category-defining exits. Most directly comparable to InterWest by thesis, stage, and Silicon Valley geography.
  • Bessemer Venture Partners: Heritage early-stage venture firm with broad IT and healthcare exposure and a multi-decade operating history; comparable to InterWest as a long-tenured generalist stage-agnostic VC.
  • New Enterprise Associates (NEA): Large-scale venture capital firm with deep IT and healthcare franchises; comparable to InterWest in sector breadth and early-stage orientation, though operating at far greater scale.
  • Greylock Partners: Premier early-stage venture firm based in Silicon Valley with strong IT focus; comparable in stage, geography, and long tenure.
  • Accel: Long-running early-stage venture capital firm with a similarly broad IT focus across enterprise and consumer software; comparable to InterWest in stage focus and tenure.

Broad incumbents

  • Sequoia Capital: Largest and most-established venture capital franchise with deep IT exposure; comparable to InterWest as a benchmark for category-defining IT investments though vastly larger in scale and active deployment.
  • Andreessen Horowitz (a16z): Major venture capital firm with a broad IT franchise and growing healthcare practice; comparable in stage and sector focus, but at far greater scale and recency of activity than InterWest.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

InterWest Partners social profiles

Digital presence

InterWest Partners financial estimates

Financial estimate

Revenue estimate

Valuation estimate

InterWest Partners leadership team

Management profile

Number of profiles

Profiles7 records

InterWest Partners funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

InterWest Partners M&A and investment

M&A and investment

M&A

Investments453 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about InterWest Partners

What does InterWest Partners do?

InterWest Partners is a venture capital firm that invests an average of $7-15 million in early-stage information technology and healthcare startups. The firm partners with entrepreneurs to provide growth capital and strategic guidance, generating returns through equity stakes in portfolio companies that exit via IPOs or acquisitions. InterWest is not currently seeking new investments and focuses on managing its existing portfolio across IT and healthcare sectors.

Is InterWest Partners a public or private company?

InterWest Partners is a private company. It is classified as management employee owned and is currently operating.

When was InterWest Partners founded?

InterWest Partners was founded in 1980. It employs 11 to 50 people.

Where is InterWest Partners based?

InterWest Partners is headquartered in Menlo Park, United States, in the North America region.

How does InterWest Partners make money?

One revenue line is on record: investment Returns.

Who are InterWest Partners's main competitors?

Direct peers on record are Venrock, Mayfield Fund, Norwest Venture Partners, Kleiner Perkins, Bessemer Venture Partners, New Enterprise Associates (NEA), Greylock Partners and Accel. Broad incumbents are Sequoia Capital and Andreessen Horowitz (a16z).

Does InterWest Partners have an API?

No public API is recorded for InterWest Partners.

What industry is InterWest Partners in?

InterWest Partners's product category is Venture Capital. Its primary akta.pro industry code is FSANACAJ, Telecom, Networking & Infrastructure Growth Equity. Its NAICS code is 523150 and its SIC code is 6211.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
InknowvationAvedro Completes New $32 Million Round of FinancingAvedro, Inc. completed a $32 million equity financing round led by InterWest Partners and OrbiMed to support the global expansion of its corneal cross-linking platform. The funding will aid in the commercialization of its Mosaic System outside the United States and further develop the PiXL procedure for refractive correction. Avedro has also re-submitted its NDA to the US FDA for its corneal cross-linking technology, with a decision expected in April 2016.VC News DailyAvedro Announces $25M in FundingAvedro, an ophthalmic pharmaceutical and medical device company and the world leader in corneal remodeling, announced it has secured $25 million in financing led by Lilly Asia Ventures with participation from existing investors OrbiMed Advisors, InterWest Partners, and HealthQuest Capital. The funding will support product development, clinical studies, and commercial expansion including sales and reimbursement support. Hongbo Lu from LAV has joined Avedro's Board of Directors, and the partnership is expected to help Avedro expand its product portfolio and global reach into Asian markets.PR NewswirePMV Pharma Secures $74 Million in Series B Financing for Cancer Drugs Targeting p53PMV Pharmaceuticals, Inc. announced the completion of a $74 million Series B financing round led by Topspin Biotech Fund with participation from Euclidean Capital and existing investors InterWest Partners, OrbiMed Advisors, and Osage University Partners. The proceeds will be used to develop and advance the company's pipeline of mutant p53 restoration drug candidates into clinical trials. p53 is the most commonly mutated protein in human cancers, with over 50 percent of all human tumors containing a p53 mutant protein.PR NewswireWellness Startup Grokker Closes Series B, Bringing Total Funding to $22.5M from SV Angel, First Round Capital, Khosla Ventures, Aspect Ventures, Interwest Partners, Comcast, and Correlation VenturesGrokker, a San Francisco-based wellness startup offering online fitness, yoga, meditation, and cooking video services, has closed a Series B funding round, bringing its total funding to $22.5 million from investors including SV Angel, First Round Capital, Khosla Ventures, Aspect Ventures, Interwest Partners, Comcast, and Correlation Ventures. As part of the round, Comcast has entered both an investment and a programming partnership, offering Grokker's service to subscribers on its platform for $6.99 per month. The company, which launched its subscription service in 2015, has grown its network to over 135 experts and serves enterprise clients including Pinterest and Synaptics as employee wellness benefits.FinSMEsReVision Optics Raises $32m in FundingReVision Optics raised $32m in equity funding led by JJDC, with participation from Canaan Partners, Domain Associates, InterWest Partners, and ProQuest Investments. The company will use the proceeds to expand U.S. commercialization of its Raindrop Near Vision Inlay and develop a marketing campaign and medical affairs team. The inlay has FDA approval and registrations in multiple countries.FinSMEsAvedro Completes $32M Equity FinancingAvedro completed a $32M equity financing led by InterWest and OrbiMed. The funds will expand global distribution of its KXL corneal cross-linking platform and commercialize the Mosaic System outside the US. The company also re-submitted its NDA to the FDA, expecting an action date in April 2016.VC News DailyAdsNative Raises $8.5M Series AAdsNative, a digital advertising technology company, closed an $8.5 million Series A funding round led by Rakuten Ventures and Interwest Partners, with participation from Onset Ventures. The funding will support the launch of AdsNative Enterprise, a platform integrating ad serving technology within publishers' existing content management systems, and the company's expansion into Asia and mobile markets. As of September 2015, AdsNative tripled its revenue from 2014 and grew its team from 10 to 23 employees.GlobeNewswireSera Prognostics Closes $20 Million in Series B FinancingSera Prognostics closed $20 million in Series B financing led by Chione, with participation from Domain Associates, InterWest Partners, and others. The company has enrolled 5,500 patients in its PAPR study, expecting results in Q2 2015. It also appointed Mansoor Raza Mirza to its board.FinSMEsPMV Pharmaceuticals Completes $30M Series A FinancingPMV Pharmaceuticals completed a $30M Series A financing led by OrbiMed, with participation from Osage University Partners and founding investor InterWest Partners. The company will use the funds to advance its pipeline of p53 targeted small molecule drugs for cancer treatment. Peter Thompson will join the board.FinSMEsBenvenue Medical Completes $64M FinancingBenvenue Medical completed a $64M financing round, led by InterWest Partners, with $40M in Series E equity and $24M in debt from Silicon Valley Bank. The funds will support US commercial expansion, manufacturing scale-up, and working capital. The company operates three spine implant products in a $9B global market.